{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:53:43Z","timestamp":1793393623815,"version":"4.5.0"},"reference-count":83,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,8]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>In 5% to 15% of patients with systemic mastocytosis (SM), SM coexists with an associated hematological neoplasm (AHN). Most patients with SM-AHN harbor a KIT mutation, mainly KIT p.D816V, together with other AHN-related genetic alterations; however, limited data exist about the frequency and clinical impact of the coexistence of both types of genetic alterations in the same vs distinct bone marrow (BM) cell compartments. Here, we analyzed 79 patients with SM-AHN classified into patients who (1) displayed distinct unrelated genetic alterations in BM mast cells (MC) and AHN cells (21\/79 [27%]); (2) shared the KIT mutation as a first genetic event (24\/79 [30%]) involving both BM MC and AHN cells, together with or without AHN-associated alterations restricted to the latter cells; (3) had AHN-associated alterations as a first event (25\/79 [32%]) present in both BM MC and AHN cells; and (4) had both alterations involving virtually all SM and AHN cells (9\/79 [11%]). Overall, patients with genetically unrelated SM and AHN more frequently showed clinical manifestations associated with SM (ie, anaphylaxis, osteoporosis, and skin lesions) together with prolonged progression-free survival (PFS), whereas those with shared genetic alterations displayed signs of more advanced disease (ie, cytopenias or organomegalies) and shorter PFS and overall survival. Our findings confirm the clinical, genetic, and prognostic heterogeneity of SM-AHN and point to its association with the underlying oncogenic profile of neoplastic MC and AHN cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018389","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:36:02Z","timestamp":1781717762000},"page":"5916-5931","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["<i>KIT<\/i>\n                    mutation and AHN-associated oncogenic profiles in systemic mastocytosis with an associated hematological neoplasm"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3013-5497","authenticated-orcid":false,"given":"Paula","family":"Navarro-Navarro","sequence":"first","affiliation":[{"name":"1Translational and Clinical Research in Cancer Program, Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca and Fundaci\u00f3n para la Investigaci\u00f3n del C\u00e1ncer de la Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain"},{"name":"2Department of Medicine, University of Salamanca, Salamanca, Spain"},{"name":"3Cytometry Service (NUCLEUS-USAL), University of Salamanca, Salamanca, Spain"},{"name":"4Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"5Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"},{"name":"6Red Espa\u00f1ola de Mastocitosis, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6871-454X","authenticated-orcid":false,"given":"Carlos M.","family":"Fern\u00e1ndez-Gim\u00e9nez","sequence":"additional","affiliation":[{"name":"1Translational and Clinical Research in Cancer Program, Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca and Fundaci\u00f3n para la Investigaci\u00f3n del C\u00e1ncer de la Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain"},{"name":"2Department of Medicine, University of Salamanca, Salamanca, Spain"},{"name":"3Cytometry Service (NUCLEUS-USAL), University of Salamanca, Salamanca, Spain"},{"name":"4Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s C.","family":"Garc\u00eda-Montero","sequence":"additional","affiliation":[{"name":"1Translational and Clinical Research in Cancer Program, Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca and Fundaci\u00f3n para la Investigaci\u00f3n del C\u00e1ncer de la Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain"},{"name":"2Department of Medicine, University of Salamanca, Salamanca, Spain"},{"name":"4Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"5Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"},{"name":"6Red Espa\u00f1ola de Mastocitosis, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1190-4473","authenticated-orcid":false,"given":"Iv\u00e1n","family":"\u00c1lvarez-Twose","sequence":"additional","affiliation":[{"name":"4Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"7Red Espa\u00f1ola de Mastocitosis, Toledo, Spain"},{"name":"8Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1757-7255","authenticated-orcid":false,"given":"Laura","family":"S\u00e1nchez-Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"7Red Espa\u00f1ola de Mastocitosis, Toledo, Spain"},{"name":"8Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5096-791X","authenticated-orcid":false,"given":"Ana","family":"Henriques","sequence":"additional","affiliation":[{"name":"7Red Espa\u00f1ola de Mastocitosis, Toledo, Spain"},{"name":"8Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5805-1391","authenticated-orcid":false,"given":"Alba","family":"P\u00e9rez-Pons","sequence":"additional","affiliation":[{"name":"1Translational and Clinical Research in Cancer Program, Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca and Fundaci\u00f3n para la Investigaci\u00f3n del C\u00e1ncer de la Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain"},{"name":"2Department of Medicine, University of Salamanca, Salamanca, Spain"},{"name":"3Cytometry Service (NUCLEUS-USAL), University of Salamanca, Salamanca, Spain"},{"name":"4Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"5Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"},{"name":"6Red Espa\u00f1ola de Mastocitosis, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9774-1558","authenticated-orcid":false,"given":"Mar\u00eda","family":"Gonz\u00e1lez-Tablas","sequence":"additional","affiliation":[{"name":"1Translational and Clinical Research in Cancer Program, Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca and Fundaci\u00f3n para la Investigaci\u00f3n del C\u00e1ncer de la Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain"},{"name":"2Department of Medicine, University of Salamanca, Salamanca, Spain"},{"name":"3Cytometry Service (NUCLEUS-USAL), University of Salamanca, Salamanca, Spain"},{"name":"4Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"5Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"},{"name":"6Red Espa\u00f1ola de Mastocitosis, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Teodosio","sequence":"additional","affiliation":[{"name":"1Translational and Clinical Research in Cancer Program, Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca and Fundaci\u00f3n para la Investigaci\u00f3n del C\u00e1ncer de la Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain"},{"name":"2Department of Medicine, University of Salamanca, Salamanca, Spain"},{"name":"3Cytometry Service (NUCLEUS-USAL), University of Salamanca, Salamanca, Spain"},{"name":"4Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"5Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8115-1086","authenticated-orcid":false,"given":"Mar\u00eda","family":"Gonz\u00e1lez-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"1Translational and Clinical Research in Cancer Program, Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca and Fundaci\u00f3n para la Investigaci\u00f3n del C\u00e1ncer de la Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain"},{"name":"2Department of Medicine, University of Salamanca, Salamanca, Spain"},{"name":"3Cytometry Service (NUCLEUS-USAL), University of Salamanca, Salamanca, Spain"},{"name":"4Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"5Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4634-8005","authenticated-orcid":false,"given":"Sergio","family":"Matarraz","sequence":"additional","affiliation":[{"name":"1Translational and Clinical Research in Cancer Program, Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca and Fundaci\u00f3n para la Investigaci\u00f3n del C\u00e1ncer de la Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain"},{"name":"2Department of Medicine, University of Salamanca, Salamanca, Spain"},{"name":"3Cytometry Service (NUCLEUS-USAL), University of Salamanca, Salamanca, Spain"},{"name":"4Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"5Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"3Cytometry Service (NUCLEUS-USAL), University of Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Barcena","sequence":"additional","affiliation":[{"name":"1Translational and Clinical Research in Cancer Program, Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca and Fundaci\u00f3n para la Investigaci\u00f3n del C\u00e1ncer de la Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain"},{"name":"2Department of Medicine, University of Salamanca, Salamanca, Spain"},{"name":"5Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8675-8207","authenticated-orcid":false,"given":"Enrique","family":"Colado","sequence":"additional","affiliation":[{"name":"9Servicio de Hematolog\u00eda, Hospital Universitario Central de Asturias, Asturias, Oviedo, Spain"},{"name":"10Fundaci\u00f3n para la Investigaci\u00f3n Biosanitaria del Principado de Asturias, Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8056-648X","authenticated-orcid":false,"given":"Jordi","family":"Esteve","sequence":"additional","affiliation":[{"name":"11Josep Carreras Leukemia Research Institute, Campus Cl\u00ednic-University of Barcelona, Barcelona, Spain"},{"name":"12Department of Hematology, Hospital Cl\u00ednic, Barcelona, Spain"},{"name":"13Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa Leonor","family":"Senent","sequence":"additional","affiliation":[{"name":"4Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"14Department of Hematology, La Fe University and Polytechnic Hospital, Valencia, Spain"},{"name":"15La Fe Health Research Institute, Hematology Research Group, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4169-4294","authenticated-orcid":false,"given":"\u00d3scar","family":"Gonz\u00e1lez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"1Translational and Clinical Research in Cancer Program, Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca and Fundaci\u00f3n para la Investigaci\u00f3n del C\u00e1ncer de la Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain"},{"name":"2Department of Medicine, University of Salamanca, Salamanca, Spain"},{"name":"5Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"},{"name":"6Red Espa\u00f1ola de Mastocitosis, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5658-0532","authenticated-orcid":false,"given":"Manuela","family":"Mollejo","sequence":"additional","affiliation":[{"name":"16Pathology Department, Complejo Hospitalario Universitario de Toledo, Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8550-0930","authenticated-orcid":false,"given":"Cristina","family":"Morales-Cabeza","sequence":"additional","affiliation":[{"name":"7Red Espa\u00f1ola de Mastocitosis, Toledo, Spain"},{"name":"8Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7965-7512","authenticated-orcid":false,"given":"Mar\u00eda","family":"Jara-Acevedo","sequence":"additional","affiliation":[{"name":"2Department of Medicine, University of Salamanca, Salamanca, Spain"},{"name":"3Cytometry Service (NUCLEUS-USAL), University of Salamanca, Salamanca, Spain"},{"name":"4Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"5Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"},{"name":"6Red Espa\u00f1ola de Mastocitosis, Salamanca, Spain"},{"name":"17Sequencing Service (NUCLEUS-USAL), University of Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0007-7230","authenticated-orcid":false,"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[{"name":"1Translational and Clinical Research in Cancer Program, Centro de Investigaci\u00f3n del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca and Fundaci\u00f3n para la Investigaci\u00f3n del C\u00e1ncer de la Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain"},{"name":"2Department of Medicine, University of Salamanca, Salamanca, Spain"},{"name":"3Cytometry Service (NUCLEUS-USAL), University of Salamanca, Salamanca, Spain"},{"name":"4Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"5Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain"},{"name":"6Red Espa\u00f1ola de Mastocitosis, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"7","key":"2026090811163283300_bib1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/ajh.26962","article-title":"Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management","volume":"98","author":"Pardanani","year":"2023","journal-title":"Am J Hematol"},{"issue":"19","key":"2026090811163283300_bib2","first-page":"1885","article-title":"Mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"2026090811163283300_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-025-00611-8","article-title":"Mastocytosis","volume":"11","author":"Akin","year":"2025","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"2026090811163283300_bib4","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"7","key":"2026090811163283300_bib5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"issue":"11","key":"2026090811163283300_bib6","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"issue":"5","key":"2026090811163283300_bib7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/1097-0142(19880901)62:5<965::AID-CNCR2820620520>3.0.CO;2-M","article-title":"Significance of systemic mast cell disease with associated hematologic disorders","volume":"62","author":"Travis","year":"1988","journal-title":"Cancer"},{"issue":"6","key":"2026090811163283300_bib8","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jcp.2003.014860","article-title":"Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge","volume":"57","author":"Horny","year":"2004","journal-title":"J Clin Pathol"},{"issue":"8","key":"2026090811163283300_bib9","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s41375-018-0121-1","article-title":"A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone","volume":"32","author":"Patnaik","year":"2018","journal-title":"Leukemia"},{"issue":"10","key":"2026090811163283300_bib10","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3324\/haematol.2019.222059","article-title":"Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions","volume":"104","author":"Valent","year":"2019","journal-title":"Haematologica"},{"issue":"6","key":"2026090811163283300_bib11","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41379-019-0447-x","article-title":"Detection of the KITD816V mutation in myelodysplastic and\/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis","volume":"33","author":"Craig","year":"2020","journal-title":"Mod Pathol"},{"issue":"18","key":"2026090811163283300_bib12","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1182\/blood-2009-05-220145","article-title":"Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies","volume":"114","author":"Pardanani","year":"2009","journal-title":"Blood"},{"issue":"7","key":"2026090811163283300_bib13","doi-asserted-by":"crossref","first-page":"e7134","DOI":"10.1002\/ccr3.7134","article-title":"A case of high-risk AML in a patient with advanced systemic mastocytosis","volume":"11","author":"Fazio","year":"2023","journal-title":"Clin Case Rep"},{"issue":"18","key":"2026090811163283300_bib14","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1182\/blood.2021010957","article-title":"Systemic mastocytosis with an associated t(8;21)(q22;q22) acute myeloid leukemia","volume":"137","author":"Wimmer","year":"2021","journal-title":"Blood"},{"issue":"4","key":"2026090811163283300_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molonc.2010.04.008","article-title":"High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V","volume":"4","author":"Fritsche-Polanz","year":"2010","journal-title":"Mol Oncol"},{"issue":"11","key":"2026090811163283300_bib16","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"2","key":"2026090811163283300_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000048186","article-title":"Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis","volume":"127","author":"Sperr","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"issue":"8","key":"2026090811163283300_bib18","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.jaip.2022.03.007","article-title":"Personalized management strategies in mast cell disorders: ECNM-AIM user\u2019s guide for daily clinical practice","volume":"10","author":"Valent","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"2026090811163283300_bib19","first-page":"132","article-title":"Mastocytosis and diffuse large B-cell lymphoma, an unlikely combination","volume":"69","author":"Schipper","year":"2011","journal-title":"Neth J Med"},{"issue":"7","key":"2026090811163283300_bib20","first-page":"1755","article-title":"Systemic mastocytosis with plasma cell dyscrasia: report of a case","volume":"32","author":"Ault","year":"2008","journal-title":"Leuk Res"},{"issue":"12","key":"2026090811163283300_bib21","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.leukres.2007.04.002","article-title":"Systemic mastocytosis in association with chronic lymphocytic leukemia: a rare diagnosis","volume":"31","author":"Keating","year":"2007","journal-title":"Leuk Res"},{"issue":"1","key":"2026090811163283300_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13000-015-0235-y","article-title":"Hodgkin\u2019s lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis","volume":"10","author":"Gasljevic","year":"2015","journal-title":"Diagn Pathol"},{"issue":"21","key":"2026090811163283300_bib23","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1182\/bloodadvances.2018020628","article-title":"Impact of somatic and germline mutations on the outcome of systemic mastocytosis","volume":"2","author":"Mu\u00f1oz-Gonz\u00e1lez","year":"2018","journal-title":"Blood Adv"},{"issue":"23","key":"2026090811163283300_bib24","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"issue":"16","key":"2026090811163283300_bib25","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.2019000932","article-title":"New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis","volume":"135","author":"Reiter","year":"2020","journal-title":"Blood"},{"key":"2026090811163283300_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-pathmechdis-031521-042618","article-title":"New insights into the pathogenesis of mastocytosis: emerging concepts in diagnosis and therapy","volume":"18","author":"Valent","year":"2023","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"2026090811163283300_bib27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients","volume":"124","author":"Escribano","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2026090811163283300_bib28","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/all.15584","article-title":"KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes","volume":"78","author":"Navarro-Navarro","year":"2023","journal-title":"Allergy"},{"issue":"6","key":"2026090811163283300_bib29","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/all.12409","article-title":"The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease","volume":"69","author":"Hoermann","year":"2014","journal-title":"Allergy"},{"issue":"10","key":"2026090811163283300_bib30","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.pas.0000138181.89743.7b","article-title":"CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens","volume":"28","author":"Sotlar","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2026090811163283300_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/1096-8652(200012)65:4<307::AID-AJH10>3.0.CO;2-F","article-title":"Mast cell disease associated with acute myeloid leukemia: detection of a new c-kit mutation Asp816His","volume":"65","author":"Pullarkat","year":"2000","journal-title":"Am J Hematol"},{"issue":"5","key":"2026090811163283300_bib32","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/path.2677","article-title":"Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD)","volume":"220","author":"Sotlar","year":"2010","journal-title":"J Pathol"},{"issue":"11","key":"2026090811163283300_bib33","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.exphem.2007.08.016","article-title":"The origin of neoplastic mast cells in systemic mastocytosis with AML1\/ETO-positive acute myeloid leukemia","volume":"35","author":"Nagai","year":"2007","journal-title":"Exp Hematol"},{"issue":"1","key":"2026090811163283300_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12308-009-0023-2","article-title":"Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia","volume":"2","author":"Pullarkat","year":"2009","journal-title":"J Hematop"},{"key":"2026090811163283300_bib35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ebiom.2019.03.089","article-title":"Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis","volume":"43","author":"Grootens","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"2026090811163283300_bib36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2353\/jmoldx.2008.070061","article-title":"Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F","volume":"10","author":"Sotlar","year":"2008","journal-title":"J Mol Diagn"},{"issue":"5","key":"2026090811163283300_bib37","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/leu.2015.4","article-title":"Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event","volume":"29","author":"Jawhar","year":"2015","journal-title":"Leukemia"},{"issue":"6","key":"2026090811163283300_bib38","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2015-07-655100","article-title":"KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression","volume":"127","author":"Garcia-Montero","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2026090811163283300_bib39","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jaci.2022.04.004","article-title":"Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022","volume":"149","author":"Arock","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2026090811163283300_bib40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/leu.2015.284","article-title":"Additional mutations in SRSF2, ASXL1 and\/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis","volume":"30","author":"Jawhar","year":"2016","journal-title":"Leukemia"},{"issue":"5","key":"2026090811163283300_bib41","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood.2018886507","article-title":"Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis","volume":"134","author":"Mu\u00f1oz-Gonz\u00e1lez","year":"2019","journal-title":"Blood"},{"issue":"7","key":"2026090811163283300_bib42","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"issue":"5","key":"2026090811163283300_bib43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/gcc.22526","article-title":"Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis","volume":"57","author":"Naumann","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"2026090811163283300_bib44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.leukres.2006.03.006","article-title":"Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone","volume":"31","author":"Pullarkat","year":"2007","journal-title":"Leuk Res"},{"issue":"1","key":"2026090811163283300_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ajh.10322","article-title":"Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations","volume":"73","author":"Pullarkat","year":"2003","journal-title":"Am J Hematol"},{"issue":"11","key":"2026090811163283300_bib46","first-page":"270","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Bento","year":"2017","journal-title":"Blood"},{"key":"2026090811163283300_bib47","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fonc.2017.00270","article-title":"The use of flow cytometry in myelodysplastic syndromes: a review","volume":"7","author":"De Souza Barroso","year":"2017","journal-title":"Front Oncol"},{"key":"2026090811163283300_bib48","first-page":"1908","article-title":"Immunophenotypic dissection of normal hematopoiesis","volume":"475","author":"van Dongen","year":"2019","journal-title":"J Immunol Methods"},{"issue":"9","key":"2026090811163283300_bib49","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"van der Velden","year":"2012","journal-title":"Leukemia"},{"issue":"1","key":"2026090811163283300_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.20008","article-title":"Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts","volume":"60","author":"van Lochem","year":"2004","journal-title":"Cytometry B Clin Cytom"},{"issue":"3","key":"2026090811163283300_bib52","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)63870-9","article-title":"One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes","volume":"162","author":"Sotlar","year":"2003","journal-title":"Am J Pathol"},{"issue":"2","key":"2026090811163283300_bib51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jmoldx.2010.10.004","article-title":"Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay","volume":"13","author":"Kristensen","year":"2011","journal-title":"J Mol Diagn"},{"issue":"3","key":"2026090811163283300_bib53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/cncr.11100","article-title":"Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia","volume":"97","author":"Rasillo","year":"2003","journal-title":"Cancer"},{"issue":"3","key":"2026090811163283300_bib54","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/cyto.10075","article-title":"Incidence of numerical chromosome aberrations in meningioma tumors as revealed by fluorescence in situ hybridization using 10 chromosome-specific probes","volume":"50","author":"Sayagu\u00e9s","year":"2002","journal-title":"Cytometry"},{"issue":"14","key":"2026090811163283300_bib55","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood-2013-04-496448","article-title":"Comprehensive mutational profiling in advanced systemic mastocytosis","volume":"122","author":"Schwaab","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2026090811163283300_bib56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"},{"issue":"24","key":"2026090811163283300_bib57","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2009.27.1361","article-title":"Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1","volume":"28","author":"Kohlmann","year":"2010","journal-title":"J Clin Oncol"},{"issue":"9","key":"2026090811163283300_bib58","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3324\/haematol.2013.100784","article-title":"Survival analysis in hematologic malignancies: recommendations for clinicians","volume":"99","author":"Delgado","year":"2014","journal-title":"Haematologica"},{"issue":"4","key":"2026090811163283300_bib59","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood.2021012694","article-title":"Frequency and prognostic impact of blood-circulating tumor mast cells in mastocytosis","volume":"139","author":"Henriques","year":"2022","journal-title":"Blood"},{"issue":"3","key":"2026090811163283300_bib81","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2352-3026(20)30400-2","article-title":"Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study","volume":"8","author":"Mu\u00f1oz-Gonz\u00e1lez","year":"2021","journal-title":"Lancet Haematol"},{"issue":"12","key":"2026090811163283300_bib83","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1016\/S2352-3026(19)30166-8","article-title":"International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study","volume":"6","author":"Sperr","year":"2019","journal-title":"Lancet Haematol"},{"issue":"31","key":"2026090811163283300_bib82","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1200\/JCO.19.00640","article-title":"MARS: mutation-adjusted risk score for advanced systemic mastocytosis","volume":"37","author":"Jawhar","year":"2019","journal-title":"J Clin Oncol"},{"issue":"3","key":"2026090811163283300_bib60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajh.23380","article-title":"Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components","volume":"88","author":"Wang","year":"2013","journal-title":"Am J Hematol"},{"issue":"12","key":"2026090811163283300_bib61","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1016\/j.jaip.2024.08.044","article-title":"Harmonization of diagnostic criteria in mastocytosis for use in clinical practice: WHO vs ICC vs AIM\/ECNM","volume":"12","author":"Valent","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"2026090811163283300_bib62","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2162-3619-3-18","article-title":"Modelling of a genetically diverse evolution of systemic mastocytosis with chronic myelomonocytic leukemia (SM-CMML) by next generation sequencing","volume":"3","author":"Rechsteiner","year":"2014","journal-title":"Exp Hematol Oncol"},{"issue":"7","key":"2026090811163283300_bib63","doi-asserted-by":"crossref","first-page":"832","DOI":"10.5858\/arpa.2011-0325-RS","article-title":"Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review","volume":"136","author":"Stoecker","year":"2012","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"2026090811163283300_bib64","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3324\/haematol.2016.146563","article-title":"Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice","volume":"101","author":"Ustun","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"2026090811163283300_bib65","doi-asserted-by":"crossref","first-page":"e85362","DOI":"10.1371\/journal.pone.0085362","article-title":"ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases","volume":"9","author":"Damaj","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"2026090811163283300_bib66","first-page":"2048","article-title":"Systemic mastocytosis: current status and challenges in 2024","volume":"9","author":"Ustun","year":"2025","journal-title":"Blood Adv"},{"issue":"4","key":"2026090811163283300_bib67","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.iac.2023.04.008","article-title":"KIT mutations and other genetic defects in mastocytosis: implications for disease pathology and targeted therapies","volume":"43","author":"Chantran","year":"2023","journal-title":"Immunol Allergy Clin North Am"},{"issue":"13","key":"2026090811163283300_bib68","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1182\/blood-2012-09-458521","article-title":"International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis","volume":"121","author":"Gotlib","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2026090811163283300_bib69","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3324\/haematol.2021.280203","article-title":"The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis","volume":"108","author":"Mei","year":"2023","journal-title":"Haematologica"},{"issue":"22","key":"2026090811163283300_bib70","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"issue":"20","key":"2026090811163283300_bib71","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood-2015-12-688705","article-title":"Comprehensive mutational profiling of core binding factor acute myeloid leukemia","volume":"127","author":"Duployez","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2026090811163283300_bib72","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1182\/bloodadvances.2019000709","article-title":"Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11","volume":"4","author":"Ishikawa","year":"2020","journal-title":"Blood Adv"},{"issue":"12","key":"2026090811163283300_bib73","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1182\/blood-2009-09-241075","article-title":"Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML","volume":"115","author":"Pollard","year":"2010","journal-title":"Blood"},{"issue":"9","key":"2026090811163283300_bib74","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/bloodadvances.2022008292","article-title":"Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry","volume":"7","author":"Kennedy","year":"2023","journal-title":"Blood Adv"},{"issue":"6","key":"2026090811163283300_bib75","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3324\/haematol.2017.163964","article-title":"The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm","volume":"102","author":"Jawhar","year":"2017","journal-title":"Haematologica"},{"issue":"8","key":"2026090811163283300_bib76","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood.V84.8.2489.2489","article-title":"Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+\/Fc epsilon RI- cell population","volume":"84","author":"Rottem","year":"1994","journal-title":"Blood"},{"issue":"8","key":"2026090811163283300_bib77","first-page":"1719","article-title":"Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification","volume":"75","author":"Aberer","year":"2020","journal-title":"Allergy"},{"issue":"7","key":"2026090811163283300_bib78","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.jid.2020.12.030","article-title":"Clinical impact of skin lesions in mastocytosis: a multicenter study of the European Competence Network on Mastocytosis","volume":"141","author":"Hadzijusufovic","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"8","key":"2026090811163283300_bib79","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11882-014-0450-8","article-title":"Anaphylaxis as a clinical manifestation of clonal mast cell disorders","volume":"14","author":"Matito","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"2026090811163283300_bib80","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.leu.2403647","article-title":"Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment","volume":"19","author":"P\u00e9rez-Andr\u00e9s","year":"2005","journal-title":"Leukemia"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/17\/5916\/2541823\/blooda_adv-2025-018389-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/17\/5916\/2541823\/blooda_adv-2025-018389-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:23:57Z","timestamp":1788881037000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/17\/5916\/569155\/KIT-mutation-and-AHN-associated-oncogenic-profiles"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":83,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026,9,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018389","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,8]]},"published":{"date-parts":[[2026,8,28]]}}}